**This article has been corrected:** The correct [Supplementary Figure S2C](#sfig2){ref-type="fig"} is given below. The authors' explanation is as follows:

![Rat bladder carcinoma AY27 cells were treated or not (i.e. untreated controls/CNTR) with Hypericin-based Photodynamic Therapy (Hyp-PDT; 150 nM Hyp incubated for 16 h followed by irradiation with light fluence of 2.70 J/cm^2^) or mitoxantrone (MTX; 1 μM)\
C. immunoblotting for other ER stress markers like upregulation of BiP/GRP78 or CHOP levels at indicated recovery time-points. The calculations based on band densitometry analysis are mentioned as applicable.](oncotarget-09-29284-g001){#sfig2}

Due to erroneous figure processing and oversight, unintended mistakes occurred during the assembly of [Supplementary Figure S2C](#sfig2){ref-type="fig"} -- specifically, the BiP/Grp78, CHOP and Actin panels for the AY27-PDT samples only. Using the source/raw data, we have now generated the correct [Supplementary Figure S2C](#sfig2){ref-type="fig"}.

The authors apologize for the oversight. The authors declare that this correction does not affect the description, interpretation, or the original conclusions of the manuscript.
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